Member Login
  1. Stocks
    2. /
  2. Hikma Pharmaceuticals PLC (LSE: HIK)
    3. /

LSE:HIK (Hikma Pharmaceuticals PLC)

About HIK

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

Investing Articles

2 FTSE 250 pharma stocks I’d buy today and hold for another five years

| Roland Head

Roland Head takes a look at two unusual pharma stocks with long-term growth potential.

Read more »

Investing Articles

Provident Financial plc isn’t the only turnaround stock I’m considering buying for my ISA

| G A Chester

G A Chester discusses whether Provident Financial plc (LON:PFG) and another fallen growth star are now brilliant recovery buys.

Read more »

Investing Articles

Two defensive growth stocks I’d buy and hold for 10 years

| Rupert Hargreaves

These two stocks are struggling today but the future could still be bright.

Read more »

Investing Articles

2 turnaround stocks I’d consider buying before 2018

| G A Chester

Could these two turnaround stocks beat the market in 2018 and beyond?

Read more »

Investing Articles

Are these two beaten-up FTSE 250 turnaround plays buys after today’s results?

| Harvey Jones

Harvey Jones says these FTSE 250 (INDEXFTSE:MCX) stocks could reward further investigation despite patchy results.

Read more »

Investing Articles

Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

| Kevin Godbold

I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player.

Read more »

Investing Articles

2 growth stocks for the long run

| Peter Stephens

These two stocks could perform well in future years.

Read more »

Investing Articles

2 turnaround stocks that could make you rich

| Bilaal Mohamed

Bilaal Mohamed picks out two battered pharmaceutical stocks that could turn out to be excellent recovery plays.

Read more »

Investing Articles

There could be hidden value in these FTSE 250 stocks

| G A Chester

G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX).

Read more »

Investing Articles

Why this battered pharma stock could be a top turnaround buy

| Roland Head

Roland Head selects his turnaround pick from two of this year's biggest pharma fallers.

Read more »

Investing Articles

Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain

| Zach Coffell

Could ongoing approval issues at Hikma Pharmaceuticals plc (LON: HIK) and rivals help GlaxoSmithKline plc (LON:GSK) preserve its dividend?

Read more »

Airplane sitting on a runway
Investing Articles

These 2 battered stocks look set for a return to growth

| Alan Oscroft

These two hot recovery prospects certainly carry some risk, but they could provide great rewards for brave investors.

Read more »